Tamoxifen to Help Testosterone Recovery After Prostate Cancer Treatment
Treatments studied
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study tests whether tamoxifen (a hormone-blocking medication) can help men's testosterone levels recover after they finish androgen deprivation therapy (ADT)—a common prostate cancer treatment that lowers testosterone. The goal is to see if tamoxifen can safely speed up testosterone recovery and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer and completed androgen deprivation therapy (ADT)—a hormone treatment that lowers testosterone—either 6 months or 18–36 months ago
- Your testosterone level is currently very low (less than 50 ng/dL), measured within 6 weeks of joining the study
- You have been off all ADT medications for at least as long as your last injection lasted (for example, 3 months if your last shot was a 3-month depot)
- You are 18 years or older and in generally good health (able to perform light activity)
- You do not have a history of blood clots, stroke, or heart rhythm problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether testosterone levels before and around radical prostate surgery affect cancer control and sexual/physical recovery. It may help doctors understand who benefits from testosterone replacement and who should not.
This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are not receiving active treatment. You may be eligible if you have confirmed low testosterone and are being monitored without intervention.
This Phase 2 study tests whether adding apalutamide to standard hormone therapy (ADT) after prostate surgery can lower the chance that prostate cancer comes back. It targets men at higher risk of recurrence based on PSA levels and a risk score from surgical findings.
This trial compares two ways of giving hormone therapy (apalutamide) along with radiation after prostate removal surgery. It aims to see which approach helps maintain quality of life while controlling cancer.
This study tests whether a structured exercise program can help you manage side effects from hormone therapy and radiation for prostate cancer. It aims to improve your overall well-being.
This trial tests a treatment called bipolar androgen therapy for men with prostate cancer that has not spread to other parts of the body and is still growing despite taking darolutamide. The goal is to see if this therapy can help control the cancer.
Hear when a new Hypogonadism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.